SCHEMBL26643160

SCHEMBL26643160

Cc1cnc(-n2cc(C)cn2)c(C(=O)O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRB2 P47870 1/20 0.36
GABRA4 P48169 1/20 0.36
GABRE P78334 1/20 0.36
GABRA6 Q16445 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26643225 0.87 EGLN1 (0.38) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL26643108 0.87 NOTUM (0.37) KDM4EMAPTL3MBTL1HPGDHTT
SCHEMBL26643068 0.80 LMNA (0.46) KDM4EMAPTALDH1A1GAAPKM
SCHEMBL17725519 0.79 MYC (0.57) KDM4EMAPTNPSR1L3MBTL1ALDH1A1
SCHEMBL1672011 0.79 HCRTR1 (0.45) KDM4EGABRPGABRDGABRA1GABRB1
SCHEMBL26643032 0.76 KDM4E (0.41) KDM4EMAPTL3MBTL1GABRPGABRD
SCHEMBL1671789 0.76 HCRTR1 (0.49) KDM4EALDH1A1GAAPKM
SCHEMBL16277507 0.75 CSNK2A1 (0.46) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL30756500 0.73 TDO2 (0.39) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL612856 0.70 KDM4E (0.48) KDM4EHPGDGABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023218023-A1 THIAZOLOARYL-METHYL SUBSTITUTED CYCLIC HYDRAZINE-N-CARBOXAMIDE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2023-11-16 WO disclosed